Theratechnologies’ supply hiccup is the second caused by third-party manufacturing problems in less than a week. On Friday, ...

No longer a far-off futuristic idea, artificial intelligence technology has seen its popularity skyrocket in recent years. | ...

In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...

Just a few months after the reveal of Ori Biotech’s automated cell and gene therapy manufacturing platform IRO, the technical ...

With its latest acquisition, women’s health outfit Organon is bringing its dermatology business to the U.S. with a potential ...

Since GSK’s Nucala and AstraZeneca’s Fasenra were approved two years apart to treat patients with severe asthma, the IL-5 ...

New biologics such as GSK's Benlysta and AstraZeneca's Saphnelo, along with off-label drugs, have been the mainstay for ...

Nearly a year after Coherus BioSciences’ on-body injector for Udenyca was rejected over external production issues, a ...

An FDA approval has officially lifted the curtain on a blockbuster market showdown between Novartis and Eli Lilly in early ...

Equipped with a $200 million investment led by Bain’s Life Science arm, Serán has set its sights on the build-out of its ...

Three months after a jury awarded $260 million to an Oregon woman who claimed her use of Johnson’s Baby Powder caused her to ...

As this year’s respiratory syncytial virus (RSV) season approaches, Beyfortus makers Sanofi and AstraZeneca are making ...